ResMed Acquires Jaysec, a Leader in Internet-Based Software Solutions for Home Medical Equipment Providers

SAN DIEGO, Feb. 10, 2015 /PRNewswire/ -- ResMed (NYSE:RMD) today announced it has acquired Jaysec, a provider of Internet-based software solutions for the home medical equipment (HME) industry. Headquartered in Knoxville, Tenn., Jaysec's products help HME providers resupply their patients and communicate with referring medical providers.

"Jaysec's products streamline key HME business practices such as resupply, allowing home medical equipment providers to focus on delivering quality care for their patients," said Raj Sodhi, president of ResMed's Healthcare Informatics Global Business Unit. "Acquiring Jaysec furthers our commitment to helping HMEs drive business efficiencies while delivering positive patient outcomes. We're excited to bring Jaysec into the ResMed fold, and we look forward to supporting existing and new customers alike."

Jaysec offers an automated resupply solution - GoJaysec - that uses interactive voice, text and secured email communications to direct patients to a self-serve portal for easy authorization of HME resupplies, including CPAP masks and accessories. This targeted, periodic communication automates the resupply process. The portal offers a cost effective solution while reducing the administrative burden for the HME.

Jaysec was founded in 2002 and currently serves nearly 100 HME customers in the U.S., including most national HME accounts as well as a smaller number of home health providers. The Jaysec products will now be offered by ResMed.

Existing Jaysec customers with questions about this announcement should contact a Jaysec client service associate directly or call (866) 467- 4897 (Monday through Friday, 7am to 6pm Central Time). For more information about Jaysec's products and services, visit

About ResMed
ResMed changes lives by developing, manufacturing and distributing medical equipment for treating, diagnosing, and managing sleep-disordered breathing, chronic obstructive pulmonary disease, and other chronic diseases. We develop innovative products and solutions to improve the health and quality of life of those who suffer from these conditions, and we work to raise awareness of the potentially serious health consequences of untreated sleep-disordered breathing. For more information on ResMed, visit

ResMed Contacts:

For News Media

For Investors

Alison Graves

Agnes Lee

Global Corporate Communications

Senior Director, Investor Relations

O: 858-836-6789

O: 858-836-5971


ResMed Inc. logo.

Logo -


To view the original version on PR Newswire, visit:

SOURCE ResMed Inc.